The Biotech-Industrial Complex Gets Ready to Define What is Human
By Stuart Newman,
CounterPunch
| 08. 16. 2019
Newly approved human-animal chimera procedures are just some of a number of scientifically and ethically questionable techniques that are being soft-pedaled and normalized on a daily basis.
Fabricating part-human-part-nonhuman animals, with features of both, seemed like something out of Greek mythology until the late 20th century. New research then on “geeps,” fully developed, viable mixtures of goats and sheep, showed that constructing such “chimeras” was a real possibility. Still, the warning by H.G. Wells, a century before, in his novel “The Island of Dr. Moreau,” that scientific experiments like this could go terribly awry, seemed fantastical. But this will soon change. At the end of July, it was reported that the biologist Juan Carlos Izpisúa Belmonte, director of a laboratory at the Salk Institute in California, produced fetal human-monkey chimeras. He did this in collaboration with researchers in China. And this month the Japanese government is expected to give the go-ahead to scientist Hiromitsu Nakauchi, leader of teams at the University of Tokyo and Stanford University in California, to conduct similar experiments with the goal of bringing human-pig chimeras to full term. These novel forms of life will soon be among us.
Dr. Nakauchi acknowledges that the concerns of Wells and later writers like Aldous...
Related Articles
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...